Central Lab Market Analysis

End-user (Biotechnology Companies, Pharmaceutical Companies, Research Institutes)

The global central lab market is segmented and analyzed for demand and supply by end-user into biotechnology companies, pharmaceutical companies, and research institutes, out of which the pharmaceutical companies segment is anticipated to hold the notable share in the global central lab market during the forecast period on account of the clinical studies of prevalent genetic illnesses such as sickle cell anemia, Parkinson's disease, and Alzheimer's disease. As per the data from World Health Organization, in the last 25 years, the prevalence of Parkinson’s disease (PD) has doubled, and more than 8.5 million people worldwide are anticipated to have PD in 2019.

Our in-depth analysis of the global central lab market includes the following segments:

By Service Type	Genetic Services Microbiology Services Biomarker Services Anatomic Pathology/Histology Specimen Management & Storage Special Chemistry Services Clinical Research & Trial Services Others
By End-User	Biotechnology Companies Pharmaceutical Companies Research Institutes

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of central lab is assessed at USD 2.62 billion.

The central lab market size was valued at USD 2.49 billion in 2024 and is projected to reach USD 5.58 billion by the end of 2037, expanding at around 6.5% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of genetic disorders, rise in genetic testing, increasing prevalence of cancer, and growing investment in R & D will drive the market growth.

North America is anticipated to account for largest industry share by 2037, led by high prevalence of infectious and chronic diseases, an increase in patient awareness about the significance of laboratory tests, increasing adoption of technological developments with proper quality, efficient and effective serve, and a significantly growing proportion of research and development in the region.

The major players in the market include Laboratory Corporation of America Holdings (Labcorp), ICON Plc, Medpace, Inc., Eurofins Scientific (Ireland) Limited, LabConnect, Cerba Research NV, Frontage Laboratories, Inc., Lambda Therapeutic Research Limited, InVitro International (IVRO), Clinical Reference Laboratory, Inc.

Central Lab Market Analysis